Co-architect of the Fudan TNBC subtypes and the metabolic and immune atlases that guide subtype-specific treatment.
Yi-Zhou Jiang is Professor of Breast Surgery at Fudan University Shanghai Cancer Center. He is co-architect of the Fudan subtypes of triple-negative breast cancer and led the multi-omic characterisation of Chinese triple-negative breast cancers, including the metabolomic and immune atlases that guide subtype-specific treatment. His publications include the genomic and transcriptomic landscape of triple-negative breast cancers and the treatment strategies it suggests. He co-leads the FUTURE trial series with Zhi-Ming Shao, with interests in multi-omics, metabolomics, proteomics and precision oncology.
| Title | Journal | Year |
|---|---|---|
| Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies | Cancer Cell | 2019 |
Shares Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Fudan University Shanghai Cancer Center, RNA sequencing & expression profiling, Triple-negative breast cancer (TNBC).
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
Shares Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Fudan University Shanghai Cancer Center.
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
Shares RNA sequencing & expression profiling, Triple-negative breast cancer (TNBC).
Shares RNA sequencing & expression profiling, Triple-negative breast cancer (TNBC).